✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

ADC Therapeutics SA

Common Name
ADC Therapeutics
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
188
Ticker
ADCT
Exchange
New York Stock Exchange
Description
ADC Therapeutics S.A. is a biotechnology company engaged in developing and commercializing antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. The primary goal...

ADC Therapeutics's Revenues Data

Explore ADC Therapeutics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric20252024
Total Revenue(USD)
81,357,000a
70,837,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind ADC Therapeutics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. ADC Therapeutics's 10-K 2025